RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 82 filers reported holding RECRO PHARMA INC in Q2 2019. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $13,000 | -97.3% | 4,700 | -98.0% | 0.00% | -100.0% |
| Q3 2020 | $489,000 | +11.1% | 233,100 | +140.8% | 0.00% | 0.0% |
| Q2 2020 | $440,000 | +633.3% | 96,800 | +1208.1% | 0.00% | – |
| Q1 2020 | $60,000 | -55.6% | 7,400 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $135,000 | -25.0% | 7,400 | -54.9% | 0.00% | – |
| Q3 2019 | $180,000 | -69.2% | 16,400 | -71.5% | 0.00% | -100.0% |
| Q2 2019 | $584,000 | +63.6% | 57,500 | -5.7% | 0.00% | +50.0% |
| Q1 2019 | $357,000 | -34.1% | 61,000 | -20.2% | 0.00% | -33.3% |
| Q4 2018 | $542,000 | -16.5% | 76,400 | -16.3% | 0.00% | 0.0% |
| Q3 2018 | $649,000 | -3.3% | 91,300 | -31.8% | 0.00% | 0.0% |
| Q2 2018 | $671,000 | -4.1% | 133,800 | +110.4% | 0.00% | 0.0% |
| Q1 2018 | $700,000 | +241.5% | 63,600 | +186.5% | 0.00% | +200.0% |
| Q4 2017 | $205,000 | +485.7% | 22,200 | +455.0% | 0.00% | – |
| Q3 2017 | $35,000 | +25.0% | 4,000 | 0.0% | 0.00% | – |
| Q2 2017 | $28,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samjo Capital LLC | 8,039,100 | $3,770,338 | 1.48% |
| First Light Asset Management, LLC | 19,676,396 | $9,228,230 | 0.88% |
| AWM Investment Company, Inc. | 10,266,144 | $4,814,822 | 0.71% |
| Caligan Partners LP | 1,689,768 | $794,191 | 0.36% |
| HighMark Wealth Management LLC | 484,985 | $227,458 | 0.19% |
| Nantahala Capital Management | 1,250,000 | $586,250 | 0.05% |
| Clear Harbor Asset Management, LLC | 938,847 | $440,319 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,249,229 | $1,992,888 | 0.03% |
| TITLEIST ASSET MANAGEMENT, LLC | 210,148 | $98,559 | 0.02% |
| ROYCE & ASSOCIATES LP | 3,285,082 | $1,540,703 | 0.02% |